• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纯化的造血干细胞在体内可分化为肝细胞。

Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.

作者信息

Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman I L, Grompe M

机构信息

StemCells, 525 Del Rey Avenue, Suite C, Sunnyvale, California 94085, USA.

出版信息

Nat Med. 2000 Nov;6(11):1229-34. doi: 10.1038/81326.

DOI:10.1038/81326
PMID:11062533
Abstract

The characterization of hepatic progenitor cells is of great scientific and clinical interest. Here we report that intravenous injection of adult bone marrow cells in the FAH(-/-) mouse, an animal model of tyrosinemia type I, rescued the mouse and restored the biochemical function of its liver. Moreover, within bone marrow, only rigorously purified hematopoietic stem cells gave rise to donor-derived hematopoietic and hepatic regeneration. This result seems to contradict the conventional assumptions of the germ layer origins of tissues such as the liver, and raises the question of whether the cells of the hematopoietic stem cell phenotype are pluripotent hematopoietic cells that retain the ability to transdifferentiate, or whether they are more primitive multipotent cells.

摘要

肝祖细胞的特性具有重大的科学和临床意义。在此我们报告,向I型酪氨酸血症动物模型FAH(-/-)小鼠静脉注射成年骨髓细胞,可挽救该小鼠并恢复其肝脏的生化功能。此外,在骨髓中,只有经过严格纯化的造血干细胞才能产生供体来源的造血和肝脏再生。这一结果似乎与诸如肝脏等组织的胚层起源的传统假设相矛盾,并提出了具有造血干细胞表型的细胞是保留转分化能力的多能造血细胞,还是更原始的多能细胞这一问题。

相似文献

1
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.纯化的造血干细胞在体内可分化为肝细胞。
Nat Med. 2000 Nov;6(11):1229-34. doi: 10.1038/81326.
2
Transplanted bone marrow regenerates liver by cell fusion.移植的骨髓通过细胞融合再生肝脏。
Nature. 2003 Apr 24;422(6934):901-4. doi: 10.1038/nature01539. Epub 2003 Mar 30.
3
Bloody liver-prometheus revised.血腥肝脏——普罗米修斯修订版。
Hepatology. 2001 Jul;34(1):212-4. doi: 10.1053/jhep.2001.0340212.
4
Characterization of the potential subpopulation of bone marrow cells involved in the repair of injured liver tissue.参与受损肝组织修复的骨髓细胞潜在亚群的特征分析。
Stem Cells. 2007 Jun;25(6):1439-47. doi: 10.1634/stemcells.2006-0656. Epub 2007 Mar 22.
5
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.骨髓单核细胞足以在肝脏中实现治疗性细胞融合。
Nat Med. 2004 Jul;10(7):744-8. doi: 10.1038/nm1062. Epub 2004 Jun 13.
6
[Differentiation potential of stem cells from bone marrow].[骨髓干细胞的分化潜能]
Med Klin (Munich). 2006 Mar 22;101 Suppl 1:182-5.
7
Failure of hepatocyte marker-expressing hematopoietic progenitor cells to efficiently convert into hepatocytes in vitro.表达肝细胞标志物的造血祖细胞在体外不能有效地转化为肝细胞。
Exp Hematol. 2006 Mar;34(3):348-58. doi: 10.1016/j.exphem.2005.12.004.
8
Stem cells: Fusion brings down barriers.干细胞:融合消除障碍。
Nature. 2003 Apr 24;422(6934):823-5. doi: 10.1038/422823a.
9
In vitro transdifferentiation of adult hematopoietic stem cells: an alternative source of engraftable hepatocytes.成人造血干细胞的体外转分化:可移植肝细胞的另一种来源。
J Hepatol. 2008 Dec;49(6):998-1007. doi: 10.1016/j.jhep.2008.05.019. Epub 2008 Jun 18.
10
C1qRp defines a new human stem cell population with hematopoietic and hepatic potential.C1qRp定义了一种具有造血和肝脏潜能的新型人类干细胞群体。
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10441-5. doi: 10.1073/pnas.162104799. Epub 2002 Jul 24.

引用本文的文献

1
Stem Cells in Regenerative Medicine: A Journey from Adult Stem Cells to Induced Pluripotent Cells.再生医学中的干细胞:从成体干细胞到诱导多能干细胞的历程。
Int J Mol Sci. 2025 Aug 26;26(17):8255. doi: 10.3390/ijms26178255.
2
Isolation, Purification, Generation, and Culture of Osteocytes.骨细胞的分离、纯化、生成及培养
Methods Mol Biol. 2025;2885:51-66. doi: 10.1007/978-1-0716-4306-8_3.
3
Role of cell-based therapies in digestive disorders: Obstacles and opportunities.基于细胞的疗法在消化系统疾病中的作用:障碍与机遇。
Regen Ther. 2025 Mar 4;29:1-18. doi: 10.1016/j.reth.2025.02.009. eCollection 2025 Jun.
4
Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectives.间充质干细胞治疗急性肝衰竭:最新进展与未来展望
Liver Res. 2021 Mar 31;5(2):53-61. doi: 10.1016/j.livres.2021.03.003. eCollection 2021 Jun.
5
Cell therapy for end-stage liver disease: Current state and clinical challenge.终末期肝病的细胞治疗:现状与临床挑战
Chin Med J (Engl). 2024 Dec 5;137(23):2808-2820. doi: 10.1097/CM9.0000000000003332. Epub 2024 Nov 18.
6
In Vivo Differentiation of Endogenous Bone Marrow-Derived Cells into Insulin-Producing Cells Using Four Soluble Factors.利用四种可溶性因子将内源性骨髓来源细胞在体内分化为胰岛素产生细胞
Diabetes Metab J. 2025 Jan;49(1):150-159. doi: 10.4093/dmj.2024.0174. Epub 2024 Oct 24.
7
Cellular Plasticity in Gut and Liver Regeneration.肠道和肝脏再生中的细胞可塑性。
Gut Liver. 2024 Nov 15;18(6):949-960. doi: 10.5009/gnl240005. Epub 2024 Jul 31.
8
Liver fibrosis pathologies and potentials of RNA based therapeutics modalities.肝纤维化病理学及基于RNA的治疗方式的潜力。
Drug Deliv Transl Res. 2024 Oct;14(10):2743-2770. doi: 10.1007/s13346-024-01551-8. Epub 2024 Mar 6.
9
Transforming Perspectives in Cardiac Cell Therapy: Hypothesis and Commentary Following Updated Results of a Pilot Study Investigating Very Long-Term Clinical Outcomes in Severe AMI Patients Following Trans-Epicardial Injection of Peripheral Blood CD34 Cells.转变心脏细胞治疗的观点:一项探索经心外膜注射外周血 CD34 细胞治疗严重 AMI 患者的非常长期临床结局的初步研究更新结果后的假说和评论。
Stem Cell Rev Rep. 2024 Jan;20(1):247-257. doi: 10.1007/s12015-023-10643-w. Epub 2023 Oct 20.
10
Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives.肝脏损伤与再生:当前认识、新方法和未来展望。
Cells. 2023 Aug 22;12(17):2129. doi: 10.3390/cells12172129.